Radiation therapy combined with hormone treatment for primary prostate cancer. Effects of radiation dose escalations and assessment of side effects
Has parts
Paper I: Acta Oncologica 45(4), Karlsdóttir, Á.; Muren, L. P.; Wentzel-Larsen, T.; Johannessen, D. C.; Bakke, A.; Øgreid, P.; Halvorsen, O. J.; Dahl, O., Radiation dose escalation combined with hormone therapy improves outcome in localised prostate cancer, pp. 454-462. Copyright 2006 Taylor & Francis. Full text not available in BORA due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1080/02841860500468943Paper II: Acta Oncologica 48(6), Karlsdóttir, Á.; Muren, L. P.; Wentzel-Larsen, T.; Johannessen, D. C.; Haukaas, S. A.; Halvorsen, O. J.; Dahl, O., Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy, pp. 874-881. Copyright 2009 Informa UK Ltd. (Informa Healthcare, Taylor & Francis AS). Full text not available in BORA due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1080/02841860902974159
Paper III: Radiotherapy and Oncology 71(1), Karlsdóttir, Á.; Johannessen, D. C.; Muren, L. P.; Wentzel-Larsen, T.; Dahl, O., Acute morbidity related to treatment volume during 3D- conformal radiation therapy for prostate cancer, pp. 43-53. Copyright 2004 Elsevier Ireland Ltd. Full text not available in BORA due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1016/j.radonc.2004.01.014
Paper IV: International Journal of Radiation Oncology Biology Physics 70(5), Karlsdóttir, Á.; Muren, L. P.; Wentzel-Larsen, T.; Dahl, O., Late gastrointestinal morbidity after 3D- conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity, pp. 1478-1486. Copyright 2008 Elsevier Inc. Full text not available in BORA due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1016/j.ijrobp.2007.08.076